Serotype 6B | |||
Post-vaccination antibody levels (mg/L) | Specificity (%) | Sensitivity (%) | Positive predictive value % (95% CI) |
0.20 | 95.1 | 0 | 0.0 (0–80.7) |
0.44 | 90.3 | 4.35 | 2.1 (0.4-11.3) |
0.69 | 85.1 | 26.1 | 7.8 (2.9-16.2) |
1.02 | 79.1 | 30.4 | 7.0 (2.9-13.9) |
1.29 | 75.1 | 39.1 | 7.0 (3.3-12.9) |
1.31 | 74.9 | 39.1 | 7.1 (3.3-13.0) |
1.45 | 73.0 | 39.1 | 6.6 (3.1-12.2) |
1.51 | 72.4 | 43.5 | 6.4 (3.0-11.9) |
1.65 | 70.3 | 43.5 | 6.6 (3.2-11.8) |
Serotype 23 F | |||
Post-vaccination antibody levels (mg/L) | Specificity (%) | Sensitivity (%) | Positive predictive value % (95% CI) |
0.18 | 95.1 | 8.7 | 0.0 (0–17.8) |
0.46 | 85.0 | 17.4 | 5.6 (1.8-13.6) |
0.71 | 80.0 | 21.7 | 4.9 (1.6-11.0) |
0.88 | 75.3 | 26.1 | 5.2 (1.9-10.9) |
1.01 | 73.0 | 34.8 | 5.9 (2.6-11.3) |
1.10 | 71.3 | 34.8 | 5.6 (2.4-10.7) |
1.11 | 71.1 | 39.1 | 6.5 (3.0-11.9) |
1.22 | 69.6 | 43.5 | 6.4 (3.1-11.4) |